Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024   •   Message from the Governor General on National Indigenous History Month   •   Statement by the Prime Minister on National Indigenous History Month   •   Medical Properties Trust Publishes Its Third Annual Corporate Responsibility Report   •   Message from the Governor General on Pride Month   •   The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought   •   Statement by Minister Khera on Filipino Heritage Month   •   Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community   •   Statement by Minister Khera on Portuguese Heritage Month   •   University of Phoenix and Executive Networks Study on Workplace Well-Being Highlights Challenges of Current Approaches in Addres   •   CMA reflects on National Indigenous History Month   •   Darwin’s Natural Pet Products Continues Ongoing Partnership with PAWS for Annual PAWS Walk   •   West Fraser Releases 2023 Sustainability Report   •   Government Regulation Creates Blue Oceans   •   Eaton Expands Reach into European Data Center Market by Making Strategic Investment in NordicEPOD   •   New Self-Help Book Empowers LGTBQ+ People, Parents, & Allies   •   ALL-TIME BEST MONTHLY SALES FOR THE KIA EV9 AND SPORTAGE SUVs LEAD KIA AMERICA TO SECOND BEST SALES MONTH IN COMPANY HISTORY IN   •   Fonon's Additive Manufacturing Technology To Transform Construction Industry   •   Statement from Ministers Gary Anandasangaree, Patty Hajdu, Dan Vandal, and Pascale St-Onge on National Indigenous History Month   •   Hope Biosciences Research Foundation Announces Topline Results of Cell Therapy Clinical Trial in Long COVID